Zdrowie i gospodarka · 22/04/2014
FDA to Hold Public Meeting on Postmarketing Requirements for Opioid Analgesics
The FDA is seeking public input on postmarketing requirements for extended-release/long-acting opioid analgesics to address serious risks associated with their long-term use, including misuse, abuse, and overdose.
Source: Federal Register — Food and Drug AdministrationOpen original release →